Our newest portfolio stocks pulled back from their recent 52-week high, so we're buying more
We are buying 300 shares of Bristol-Myers Squibb at approximately $58 each. Following Wednesday's trade, Jim Cramer's Charitable Trust will…
markets
Eli Lilly's obesity drug beats rival in head-to-head trial, where Cramer thinks stock will be next
The new trial data has cemented Club's lead position behind Eli Lilly in the highly competitive anti-obesity drug race. Eli…
Can Starbucks solve long lines at its airport cafes?
Customers wait in a long line at a Starbucks coffee shop in a terminal at Miami International Airport in Miami…
2 health stocks are buys. They're pretty disappointed with Trump RFK Jr.'s pick for HHS
We are purchasing 25 shares of Danaher at approximately $229 each. Following Monday's trade, Jim Cramer's Charitable Trust will own…
Dental Supply Stocks Rise Due to RFK's Anti-Fluoride Stance and Activist Involvement
Robert F. Kennedy Jr. attends a campaign event for Republican presidential candidate and former US President Donald Trump in Milwaukee,…
Jim Cramer's Top 10 Things to Watch for in the Stock Market on Friday
My Top 10 Things to Watch for Friday, Nov. 15 1. President-elect Donald Trump's decision to nominate prominent vaccine skeptic…
Jim Cramer on Eli Lilly (LLY) after Trump picks RFK Jr. to lead HHS
Enthusiasm for Eli Lilly, the club's holding company, needs to be tempered, at least for now, as Wall Street grapples…
Novo Nordisk Q3 2024 Results
Jakub Porzycki | Nurfoto | fake images Novo Nordisk on Wednesday reported a beat in third-quarter sales of its blockbuster…
We are increasing our price target on GEHC, looking beyond a mixed quarter to next year's catalysts.
GE Healthcare reported a mixed quarter before Wednesday's opening bell. While revenue declined slightly, an improvement in earnings along with…
Abbott 'very cheap' after surprising legal victory validates our conviction
Shares of Abbott Laboratories rose on Friday after the Club holding company scored a surprise victory in a trial into…